Study Assessing the Long Term Safety of Pazopanib in Cancer Patients

• Research type

  Research Study

• Full title

  An Open-Label, Phase Ib Study to Assess the Long-Term Safety Profile of Pazopanib in Cancer Patients

• IRAS ID

  17304

• Sponsor organisation

  GlaxoSmithKline Research & Development Limited

• Eudract number

  2006-005528-17

• Clinicaltrials.gov Identifier

  NCT00387205

• Research summary

  N/A

• REC name

  London - Brent Research Ethics Committee

• REC reference

  09/H0717/68

• Date of REC Opinion

  9 Oct 2009

• REC opinion

  Favourable Opinion